Voglio sapere a riguardo di…

8794

Federal Register / Vol. 86, No. 25 / Tuesday, February 9, 2021 / Notices
utility of the proposed information collection for the proper performance of the agencys functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.

State health benefits high risk pools, and insurance issuers hereon referred to as issuers, this information is processed by contractors for display on the HealthCare.gov website. The information that is provided helps the general public make educated decisions about their choice in organizations providing private health care insurance.
Information collected quarterly from insurance issuers is used to populate the Plan Finder application to show individuals their options, to provide some profile information, and to coordinate the data collection with Oversight collections to reduce the burden on issuers and the Federal Government. Collecting information consistent with the SBC standards allows consumers to access this information in a consistent manner.
Form Number: CMS10320 OMB
control number 09381086; Frequency:
Occasionally; Affected Public: State, Local, and Tribal Governments; Number of Respondents: 700; Number of Responses: 700; Total Annual Hours:
78,675. For questions regarding this collection contact Kimberlee Heckstall at 4107861647.

Comments on the collections of information must be received by the OMB desk officer by March 11, 2021.
ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/
PRAMain. Find this particular information collection by selecting Currently under 30-day ReviewOpen for Public Comments or by using the search function.
To obtain copies of a supporting statement and any related forms for the proposed collections summarized in this notice, you may make your request using one of following:
1. Access CMS website address at website address at https www.cms.gov/
Dated: February 3, 2021.
Regulations-and-Guidance/Legislation/
William N. Parham, III, PaperworkReductionActof1995/PRADirector, Paperwork Reduction Staff, Office Listing.html.
DATES:

FOR FURTHER INFORMATION CONTACT:

William Parham at 410 7864669.
Under the Paperwork Reduction Act of 1995 PRA
44 U.S.C. 35013520, federal agencies must obtain approval from the Office of Management and Budget OMB for each collection of information they conduct or sponsor. The term collection of information is defined in 44 U.S.C.
35023 and 5 CFR 1320.3c and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506c2A of the PRA 44 U.S.C.
3506c2A requires federal agencies to publish a 30-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice that summarizes the following proposed collections of information for public comment:
1. Type of Information Collection Request: Extension; Title of Information Collection: Health Care Reform Insurance Web Portal; Use: Upon collection of the data collection requirements from individual States,
khammond on DSKJM1Z7X2PROD with NOTICES

SUPPLEMENTARY INFORMATION:

VerDate Sep<11>2014

17:07 Feb 08, 2021

Jkt 253001

of Strategic Operations and Regulatory Affairs.

FR Doc. 202102580 Filed 2821; 8:45 am BILLING CODE 412001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice.
AGENCY:

The Department of Health and Human Services HHS notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities IITFs currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine or Oral Fluid Mandatory Guidelines.
FOR FURTHER INFORMATION CONTACT:
Anastasia Donovan, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N06B, SUMMARY:

PO 00000

Frm 00043

Fmt 4703

Sfmt 4703

Rockville, Maryland 20857; 240276
2600 voice; Anastasia.Donovan@
samhsa.hhs.gov email.
SUPPLEMENTARY INFORMATION: In accordance with Section 9.19 of the Mandatory Guidelines, a notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF
certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines.
If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program NLCP
during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter.
This notice is also available on the internet at https www.samhsa.gov/
workplace/resources/drug-testing/
certified-lab-list.
The Department of Health and Human Services HHS notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities IITFs currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs Mandatory Guidelines using Urine and of the laboratories currently certified to meet the standards of the Mandatory Guidelines using Oral Fluid.
The Mandatory Guidelines using Urine were first published in the Federal Register on April 11, 1988 53
FR 11970, and subsequently revised in the Federal Register on June 9, 1994 59
FR 29908; September 30, 1997 62 FR
51118; April 13, 2004 69 FR 19644;
November 25, 2008 73 FR 71858;
December 10, 2008 73 FR 75122; April 30, 2010 75 FR 22809; and on January 23, 2017 82 FR 7920.
The Mandatory Guidelines using Oral Fluid were first published in the Federal Register on October 25, 2019
84 FR 57554 with an effective date of January 1, 2020.
The Mandatory Guidelines were initially developed in accordance with Executive Order 12564 and section 503
of Public Law 10071 and allowed urine drug testing only. The Mandatory Guidelines using Urine have since been revised, and new Mandatory Guidelines allowing for oral fluid drug testing have been published. The Mandatory Guidelines require strict standards that laboratories and IITFs must meet in order to conduct drug and specimen validity tests on specimens for federal agencies. HHS does not allow IITFs to conduct oral fluid testing.
To become certified, an applicant laboratory or IITF must undergo three
E:FRFM09FEN1.SGM

09FEN1